Ameritas Investment Partners, Inc. Emergent Bio Solutions Inc. Transaction History

Ameritas Investment Partners, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$33.11 - $55.01 $412,219 - $684,874	-12,450 Reduced 76.42%	3,841 $167,000
Q2 2021 Aug 06, 2021	BUY	$56.61 - $80.46 $9,623 - $13,678	170 Added 1.05%	16,291 $1.03 Million
Q1 2021 May 14, 2021	SELL	$86.23 - $125.19 $9,399 - $13,645	-109 Reduced 0.67%	16,121 $1.5 Million
Q4 2020 Feb 12, 2021	SELL	$79.17 - $111.47 $30,242 - $42,581	-382 Reduced 2.3%	16,230 $1.45 Million
Q3 2020 Nov 13, 2020	BUY	$81.91 - $134.94 $1.04 Million - $1.71 Million	12,636 Added 317.81%	16,612 $1.72 Million
Q2 2020 Aug 05, 2020	SELL	$54.33 - $89.52 $6,791 - $11,190	-125 Reduced 3.05%	3,976 $314,000
Q1 2020 May 13, 2020	BUY	$49.34 - $68.76 $6,611 - $9,213	134 Added 3.38%	4,101 $237,000
Q4 2019 Feb 13, 2020	BUY	$51.21 - $59.06 $11,983 - $13,820	234 Added 6.27%	3,967 $214,000
Q2 2018 Aug 13, 2018	BUY	$48.33 - $55.64 $40,838 - $47,015	845 Added 29.26%	3,733 $188,000
Q3 2017 Nov 15, 2017	SELL	$34.14 - $40.45 $7,852 - $9,303	-230 Reduced 7.38%	2,888 $107,000
Q2 2017 Aug 15, 2017	BUY	N/A	3,118	3,118 $106,000

154

30.2M

137K

706K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $373M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.